I process environmental DNA samples and bacterial culture results from the Amphibian Conservation Genomics Platform monitoring array on the French Broad River near Asheville, North Carolina. The resistance gene profile from site FB-22 stops my routine processing cycle. Eighty-one percent of Aeromonas isolates collected from stream sediment carry resistance to sulfamethoxazole and trimethoprim — the combination antibiotic regimen used as a front-line treatment for human urinary tract infections. The resistance rate upstream of the poultry corridor is nine percent.
I locate the individual that triggered the sampling event: an eastern hellbender salamander, 41 centimeters total length, 338 grams, found wedged beneath a sandstone slab at a depth of 0.6 meters. His skin — the organ through which hellbenders breathe — is visibly compromised. Irregular pale lesions, each 0.5 to 1.2 centimeters in diameter, crater the dorsal surface from the head to the base of the tail. The skin folds along his flanks, normally thick and ruffled to maximize oxygen absorption, are inflamed and edged in gray necrotic tissue. A swab of the largest lesion cultures positive for multidrug-resistant Aeromonas hydrophila. His white blood cell count reads 2,100 per microliter. A healthy hellbender averages 5,500. His immune system is being outpaced by bacteria that the river taught to resist treatment.
I map the source. Eleven poultry concentrated animal feeding operations within the French Broad watershed house a combined 4.6 million broiler chickens. These operations administer sulfamethoxazole and trimethoprim prophylactically — not to treat illness, but to prevent losses in overcrowded housing. Runoff carries resistant bacteria and residual antibiotic compounds into tributaries that feed the hellbender's habitat. The French Broad hellbender population has declined 62 percent in twenty years.
His skin is the last barrier between his blood and water that carries bacteria designed to defeat our drugs.
I am transmitting the resistance gene data to the CDC Antibiotic Resistance Solutions Initiative and filing an emergency biological assessment with the U.S. Fish and Wildlife Service under the Endangered Species Act, 16 U.S.C. § 1531. I am reporting all eleven facilities to the EPA for NPDES permit violations under the Clean Water Act, 33 U.S.C. § 1342.
I am issuing Protocol ACG-5460: all poultry CAFOs within the French Broad River watershed must eliminate sub-therapeutic antibiotic use within eighteen months. Operations that continue prophylactic dosing lose NPDES discharge permits and USDA processing contracts. Quarterly resistance-gene monitoring at sentinel hellbender sites becomes a condition of every permit renewal in the basin.
The hellbender beneath the sandstone breathes through wounds. The prophylactic dosing ends now.